Back to Screener

Healthcare

Humacyte, Inc.(HUMA)

Live Price

Offline

$0.62

-11.17% today

1Y Change

-55.79%

Window

Jun 30, 2025 โ†’ Jun 18, 2026

Market Cap
$130.00M
Revenue Growth
0.0%
EPS Growth
+79.4%
Dividend Yield
0.0%

Coverage: 244 bars ยท Jun 30, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Humacyte, Inc. (HUMA) is a Healthcare stock with a market cap of $130.00M and listed on NASDAQ. The stock last traded around $0.62 and down 55.8% across the available one-year price window (Jun 30, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +79.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +79.4%, free cash flow -6.3% with operating margin -5306.0% and ROIC -107.7%. Valuation already assumes a fairly strong business story at price/sales 64.8. Stock Foundry combines HUMA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

HUMA vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

HUMA trails SPY

HUMA is 76.65 pts behind over the shared 1Y window.

HUMA had 69.80 pts deeper max drawdown than SPY.

HUMA beat SPY in 0 of 2 calendar years shown and trailed in 2.

HUMA

-55.79%

Normalized return

SPY

+20.86%

S&P 500

Excess Return

-76.65 pts

Relative to SPY

HUMA Max Drawdown

-78.94%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

HUMASPY

Calendar-Year Returns

Uses the longest available daily history for HUMA and SPY.

YearHUMASPYExcessLeader
2026-5.23%+6.71%-11.94 ptsSPY
2025-51.67%+11.19%-62.87 ptsSPY

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 12, 26
โ€”
Est -0.10
โ€”
โ€”
Est 2239.3B
โ€”
May 12
โ€”
Mar 27, 26
โ€”
-0.13
Est -0.13
0.0%
467.0B
Est 1349.3B
-65.4%
Mar 27
โ€”
Nov 12, 25
โœ“
-0.14
Est -0.17
+17.6%
753.0B
Est 1349.0B
-44.2%
Nov 12
โ€”
Aug 11, 25
โœ—
-0.24
Est -0.15
-60.0%
301.0B
Est 917.8B
-67.2%
Aug 11
โ€”
May 13, 25
โœ“
-0.10
Est -0.19
+47.4%
517.0B
Est 764.8B
-32.4%
May 13
โ€”
Mar 28, 25
โœ“
-0.16
Est -0.23
+30.4%
7228.0B
Est 640.2B
+1029.0%
Mar 28
โ€”
Nov 8, 24
โœ—
-0.33
Est -0.26
-26.9%
โ€”
Est 214.3B
โ€”
Nov 8
โ€”
Aug 13, 24
โœ—
-0.27
Est -0.23
-17.4%
โ€”
Est โ€”
โ€”
Aug 13
โ€”
May 10, 24
โœ—
-0.29
Est -0.23
-26.1%
โ€”
Est โ€”
โ€”
May 10
โ€”
Mar 22, 24
โœ“
-0.24
Est -0.25
+4.0%
10790.0B
Est 60.0B
+17883.3%
Mar 22
โ€”
Nov 9, 23
โ€”
-0.25
Est -0.25
0.0%
โ€”
Est 70.0B
โ€”
Nov 9
โ€”
Aug 14, 23
โ€”
-0.22
Est -0.22
0.0%
โ€”
Est 70.0B
โ€”
Aug 14
โ€”
May 12, 23
โ€”
-0.22
Est -0.22
0.0%
โ€”
Est 170.0B
โ€”
May 12
โ€”
Mar 24, 23
โœ“
-0.21
Est -0.24
+12.5%
5.0B
Est 200.0B
-97.5%
Mar 24
โ€”
Nov 10, 22
โœ—
-0.25
Est -0.21
-19.1%
31.0B
Est 203.5B
-84.8%
Nov 10
โ€”
Aug 12, 22
โœ“
-0.19
Est -0.22
+13.6%
1301.0B
Est 235.4B
+452.7%
Aug 12
โ€”
May 13, 22
โœ—
-0.22
Est -0.21
-4.8%
233.0B
Est 235.4B
-1.0%
May 13
โ€”
Mar 29, 22
โœ—
-0.22
Est -0.19
-15.8%
177.0B
Est 245.7B
-27.9%
Mar 29
โ€”
Nov 12, 21
โœ—
-0.72
Est -0.21
-242.9%
241.0B
Est โ€”
โ€”
Nov 12
โ€”
Aug 16, 21
โœ“
-0.17
Est -0.56
+70.2%
690.0B
Est โ€”
โ€”
Aug 16
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar